Market closed

CorMedix/$CRMD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About CorMedix

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Ticker

$CRMD
Trading on

Industry

Pharmaceuticals

Employees

83

CorMedix Metrics

BasicAdvanced
$652M
Market cap
-
P/E ratio
-$0.80
EPS
1.61
Beta
-
Dividend rate
$652M
1.61
$12.86
$2.89
1.4M
3.958
3.431
0.669
0.948
-839.64%
-37.69%
-65.04%
50.674
10.59
10.94
-11.067
41,184.20%
-5.78%
300.94%
2.93%

What the Analysts think about CorMedix

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for CorMedix stock.

CorMedix Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CorMedix Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CRMD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for CorMedix stock?

CorMedix (CRMD) has a market cap of $652M as of November 22, 2024.

What is the P/E ratio for CorMedix stock?

The price to earnings (P/E) ratio for CorMedix (CRMD) stock is 0 as of November 22, 2024.

Does CorMedix stock pay dividends?

No, CorMedix (CRMD) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next CorMedix dividend payment date?

CorMedix (CRMD) stock does not pay dividends to its shareholders.

What is the beta indicator for CorMedix?

CorMedix (CRMD) has a beta rating of 1.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.